Get 1 Year of Cigar Aficionado for Just $24.95 + A Free Gift!

Legislation

FDA Finalizes Rules For Premarket Review—Premium Sector Still Exempt

Jan 20, 2021 | By Gregory Mottola
FDA Finalizes Rules For Premarket Review—Premium Sector Still Exempt

In an effort to clarify the sometimes convoluted application process for new tobacco products, the U.S. Food & Drug Administration, which regulates the sale of tobacco, has finalized its foundational rules for its premarket review process, meaning that there should be greater clarity, detail and information regarding the requirements for pathways to market. However, a court ruling from August of 2020 currently exempts the premium cigar industry from the regulation.

The two major pathways to market for new cigars and other tobacco products are either a premarket tobacco product application (PMTA) or substantial equivalence (SE). The FDA believes that the application process for either pathway is now more effective and efficient, providing more details and insight as to the necessary steps required by a manufacturer looking to introduce new tobacco products to the market.

“The rules enable greater transparency and efficiency of the FDA’s critical task of reviewing applications for tobacco products before new products can be sold in the United States and they describe information that any company must provide if they seek to market a new tobacco product in this country, fulfilling the promise of the Tobacco Control Act,” said FDA commissioner Stephen M. Hahn, M.D. in a statement released yesterday.

The final rules will be effective 30 days after publication in the Federal Register, but in the organization’s official statement, the FDA added that it’s currently prohibited from enforcing these premarket requirements for premium cigars. This exemption is due to a court ruling handed down by Judge Mehta last summer granting some regulatory relief to the premium cigar industry.

“Because of a pending lawsuit, this premarket approval process does not apply to handmade cigars unless they are flavored,” said Drew Newman, general counsel for J.C. Newman Cigar Co., adding that the cigar industry’s lawsuit against the FDA is still ongoing. “Yesterday’s announcement is not permanent relief for premium cigars, however, it is a good step forward.”

Newman also points out that the FDA has codified the definition of a premium cigar into law for the first time.

The FDA began regulating the premium cigar industry more than four years ago when it published its Final Deeming Rule in May of 2016.

FDA

More in Legislation

See all
D.C. Court Rules Against Cigar Industry, Rejects Appeal In FDA Lawsuit

D.C. Court Rules Against Cigar Industry, Rejects Appeal In FDA Lawsuit

A Washington D.C. Court of Appeals has delivered a blow to the cigar industry.

Jul 21, 2021
Bill To Exempt Premium Cigars from FDA Regulation Returns to House

Bill To Exempt Premium Cigars from FDA Regulation Returns to House

The cigar bill is back—again.

Jun 22, 2021
J.C. Newman Hoping To Import Cuban Tobacco

J.C. Newman Hoping To Import Cuban Tobacco

Newman is asking the U.S. to rethink its position on importing Cuban tobacco leaf.

Jun 3, 2021
Michigan Tax Cap Bill Passes in House of Representatives

Michigan Tax Cap Bill Passes in House of Representatives

The Great Lake State is one step closer to making its tobacco tax cap permanent.

May 19, 2021
California Cigar Tax to Increase in July

California Cigar Tax to Increase in July

California’s state tobacco tax will increase by 11.5 percent on the first of July.

May 18, 2021
FDA Aims to Ban Flavored Cigars

FDA Aims to Ban Flavored Cigars

If you’re one to smoke a flavored cigar, your days of enjoying a smoke like this might be numbered.

Apr 29, 2021
z